Table 3.
Biomarker | Geometric Mean (95% CI)b |
Ratio (95% CI) | PWeek 14 vs Week 24 | PChange Difference by BMI | |
---|---|---|---|---|---|
Week 14 | Week 24 | ||||
Adiponectin, μg/mL | |||||
All women | 14.38 (12.52–16.52) | 13.04 (11.21–15.17) | 0.91 (0.84–0.97) | .008 | .51 |
BMI < 30 kg/m2 | 17.04 (14.31–20.29) | 15.18 (12.49–18.46) | 0.89 (0.81–0.98) | .01 | |
BMI ≥ 30 kg/m2 | 11.42 (9.37–13.93) | 10.68 (8.57–13.30) | 0.93 (0.84–1.05) | .23 | |
Leptin, ng/mL | |||||
All women | 25.65 (20.89–31.48) | 23.63 (18.67–29.90) | 0.92 (0.80–1.07) | .27 | .06 |
BMI < 30 kg/m2 | 18.32 (14.48–23.18) | 15.03 (11.65–19.38) | 0.82 (0.68–0.99) | .04 | |
BMI ≥ 30 kg/m2 | 40.31 (30.51–53.27) | 43.81 (32.78–58.56) | 1.09 (0.86–1.37) | .47 | |
A/L ratio | |||||
All women | 0.56 (0.42–0.73) | 0.56 (0.41–0.75) | 1.00 (0.85–1.17) | >.99 | .18 |
BMI < 30 kg/m2 | 0.92 (0.68–1.25) | 1.01 (0.73–1.40) | 1.09 (0.89–1.34) | .39 | |
BMI ≥ 30 kg/m2 | 0.28 (0.20–0.40) | 0.25 (0.17–0.36) | 0.88 (0.68–1.13) | .31 |
Ten women were excluded from these analyses due to insufficient serum samples for completion of adipokine measurements.
Adiponectin and leptin were not normally distributed and therefore were natural log transformed for normality; back-transformed data (geometric means and 95% CIs) are presented for ease of interpretation.